mecobalamin + eperisone + nonsteroidal anti-inflammatory drug

This is a fixed-dose combination of three drugs: mecobalamin (a form of vitamin B12), eperisone (a centrally acting muscle relaxant), and a nonsteroidal anti-inflammatory drug (NSAID; specific agent not defined here—commonly diclofenac, ibuprofen, or meloxicam in marketed combinations). The formulation is intended for enhanced management of musculoskeletal or peripheral pain syndromes characterized by pain, inflammation, and muscle spasm. - **Mecobalamin** contributes neurotrophic and neuroprotective effects, supporting remyelination and nerve recovery. - **Eperisone** acts as a muscle relaxant mainly by inhibiting central and peripheral neuronal pathways, reducing muscle hypertonicity and improving mobility without marked sedation. - **NSAIDs** provide anti-inflammatory, analgesic, and antipyretic effects by inhibition of cyclooxygenase (primarily COX-2) and reduction of pro-inflammatory mediators (prostaglandins, leukotrienes). *Mechanistic studies and clinical data suggest that the triple combination exerts synergistic benefits: reduced inflammation, faster pain relief, improved mobility, and direct neuroprotection, with a favorable safety profile and lower risk of NSAID-related adverse events compared to higher-dose NSAID monotherapy. Primary indications include low back pain, cervical spondylosis, muscle spasm, and other pain conditions associated with muscle stiffness and nerve involvement.*[1][2][3][5][6]